Synchronous colorectal carcinoma: predisposing factors and characteristics

被引:22
作者
Chin, C. -C. [1 ]
Kuo, Y. -H. [1 ]
Chiang, J. -M. [2 ]
机构
[1] Chang Gung Mem Hosp, Div Colon & Rectal Surg, Dept Surg, Chiayi, Taiwan
[2] Chang Gung Mem Hosp, Dept Surg, Div Colon & Rectal Surg, Linkou, Taiwan
关键词
Colorectal cancer; synchronous colorectal cancer; medical illness; hypertension; liver cirrhosis; prognosis; MICROSATELLITE INSTABILITY; CLINICAL-FEATURES; DIABETES-MELLITUS; CANCER; RISK; PROGNOSIS; POPULATION; ADENOCARCINOMA; DIAGNOSIS; CIRRHOSIS;
D O I
10.1111/codi.14539
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim Whether some diseases are related to the occurrence of synchronous colorectal carcinoma (sCRC) is unknown. Investigating the risk factors and presentation of sCRC could aid in the treatment of patients with colorectal cancer (CRC). The prognosis of sCRC compared with that of solitary CRC remains unclear. Methods A total of 17 093 CRC patients were recruited between 1st January 1995 and 31th December 2016. The risk factors of sCRC development were assessed using univariate and multivariate logistic regression. The effect of sCRC on survival was analysed using the multivariate Cox regression model. Results The prevalence of sCRC was 5.6% in this study. The independent risk factors of sCRC development were advanced age (P < 0.001), male sex (P < 0.001), hereditary cancer (P < 0.001), hypertension (P < 0.001) and liver cirrhosis (P = 0.024). Compared with solitary CRC, a higher number of patients with sCRC presented with an abnormal carcinoembryonic antigen (CEA) level (P = 0.011), anaemia (P < 0.001) and hypoalbuminemia (P < 0.001). Multivariate analysis revealed that sCRC was a significant factor for poor survival in patients at TNM Stage I [hazard ratio (HR) = 1.86; P < 0.001], Stage II (HR = 1.65; P < 0.001) and Stage III (HR = 1.40; P < 0.001). Conclusions In addition to hypertension and liver cirrhosis, other risk factors for sCRC were identified in this study. The prognosis of patients with sCRC was significantly worse than that of those with solitary CRC through TNM Stages I to III. Anaemia, abnormal CEA and hypoalbuminemia were more commonly seen in patients with sCRC.
引用
收藏
页码:432 / 440
页数:9
相关论文
共 40 条
[1]  
Bekdash B, 1997, BRIT J SURG, V84, P1442
[2]   Synchronous and "Early" metachronous colorectal adenocarcinoma - Analysis of prognosis and current trends [J].
Chen, HS ;
Sheen-Chen, SM .
DISEASES OF THE COLON & RECTUM, 2000, 43 (08) :1093-1099
[3]   Increased Risk of Gastrointestinal Malignancy in Patients with Diabetes Mellitus and Correlations with Anti-Diabetes Drugs: A Nationwide Population-based Study in Taiwan [J].
Chiu, Chun-Chih ;
Huang, Chin-Chou ;
Chen, Yu-Chun ;
Chen, Tzeng-Ji ;
Liang, Ying ;
Lin, Shing-Jong ;
Chen, Jaw-Wen ;
Leu, Hsin-Bang ;
Chan, Wan-Leong .
INTERNAL MEDICINE, 2013, 52 (09) :939-946
[4]   Association of Type 2 Diabetes and Colon Adenomas [J].
Rodney Eddi ;
Arya Karki ;
Anish Shah ;
Vincent A. DeBari ;
Joseph R. DePasquale .
Journal of Gastrointestinal Cancer, 2012, 43 (1) :87-92
[5]   SYNCHRONOUS COLORECTAL-CANCER IN AN ORIENTAL POPULATION [J].
EU, KW ;
SEOWCHOEN, F ;
GOH, HS .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1993, 8 (04) :193-196
[6]  
Fante R, 1996, CANCER, V77, P2013, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2013::AID-CNCR8>3.0.CO
[7]  
2-R
[8]   Distinct Metabolic Profiles are Associated with Colorectal Adenomas and Serrated Polyps [J].
Fliss-Isakov, Naomi ;
Zelber-Sagi, Shira ;
Webb, Muriel ;
Halpern, Zamir ;
Shibolet, Oren ;
Kariv, Revital .
OBESITY, 2017, 25 :S72-S80
[9]   Liver cirrhosis, other liver diseases, pancreatitis and subsequent cancer: record linkage study [J].
Goldacre, Michael J. ;
Wotton, Clare J. ;
Yeates, David ;
Seagroatt, Valerie ;
Collier, Jane .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (05) :384-392
[10]   A COMPARISON OF MULTIPLE SYNCHRONOUS COLORECTAL-CANCER IN ULCERATIVE-COLITIS, FAMILIAL POLYPOSIS-COLI, AND DENOVO CANCER [J].
GREENSTEIN, AJ ;
SLATER, G ;
HEIMANN, TM ;
SACHAR, DB ;
AUFSES, AH .
ANNALS OF SURGERY, 1986, 203 (02) :123-128